Corrigendum to 'Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study' [J Hepatol 67 (2017) 940-949]
J Hepatol. 2020 Mar;72(3):595-596.
doi: 10.1016/j.jhep.2019.11.023.
Epub 2020 Jan 9.
1 Service d'hépato-gastroentérologie, CHU Toulouse, Toulouse, France.
2 UCL Institute of Hepatology, Royal Free Hospital, University College London, London, United Kingdom.
3 DHU UNITY, Service d'hépatologie, Hôpital Beaujon, Clichy and Université Paris Diderot and Inserm U1149, Paris, France.
4 Department of Gastroenterology/Hepatology, Endocrinology and Nephrology, Klinikum Klagenfurt am Wörthersee, Klagenfurt, Austria.
5 Department of Hepatology, Bristol Royal Infirmary, Bristol, United Kingdom.
6 Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, VHIR, Universitat Autònoma de Barcelona, CIBERehd, Barcelona, Spain.
7 Facoltà di Medicina e Chirurgia, Università degli Studi di Padova, Padova, Italy.
8 Hepato-pancreatic-biliary and Liver Transplantation Surgery, Royal Free Hospital, University College London, London, United Kingdom.
9 Center for Outcomes Research in Liver Disease, Washington DC.
10 Department of Medicine, Inova Fairfax Hospital, Falls Church, VA.
11 Sequana Medical AG, Zurich, Switzerland.
12 Medicalwriters.com, Zurich, Switzerland.
13 Synergus AB, Danderyd, Sweden.
14 Synergus AB, Danderyd, Sweden; Health Outcomes and Economic Evaluation Research Group, Department of Learning, Information, Management and Ethics, Karolinska Institutet, Stockholm, Sweden and Division of Epidemiology and Global Health, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
15 UCL Institute of Hepatology, Royal Free Hospital, University College London, London, United Kingdom. Electronic address: r.jalan@ucl.ac.uk.